Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study.

Autor: Touchefeu, Y.1,2 (AUTHOR) yann.touchefeu@chu-nantes.fr, Bailly, C.1 (AUTHOR), Frampas, E.3 (AUTHOR), Eugène, T.1 (AUTHOR), Rousseau, C.4 (AUTHOR), Bourgeois, M.1 (AUTHOR), Bossard, C.5 (AUTHOR), Faivre-Chauvet, A.1 (AUTHOR), Rauscher, A.6 (AUTHOR), Masson, D.7 (AUTHOR), David, A.3 (AUTHOR), Cerato, E.8 (AUTHOR), Carlier, T.1 (AUTHOR), Sharkey, R. M.9 (AUTHOR), Goldenberg, D. M.9,10 (AUTHOR), Barbet, J.11 (AUTHOR), Kraeber-Bodere, F.1,12 (AUTHOR), Bodet-Milin, C.1 (AUTHOR)
Zdroj: European Journal of Nuclear Medicine & Molecular Imaging. Mar2021, Vol. 48 Issue 3, p874-882. 9p. 2 Color Photographs, 2 Charts.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje